Clinical Trials Sponsored by Cancer Research Institute, NY, USA

Total 4794 results

H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Withdrawn

Management of Metastatic Breast Cancer in Frail Patients

Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
USDA Beltsville Human Nutrition Research Center
United States Army Research Institute of Environmental Medicine

Completed

Metabolic Flexibility as a Biomarker of Adaptation to Diet and Exercise Challenges

Healthy Volunteers

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Cancer Prevention Research Institute of Texas

Recruiting

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

Smoking | Lung Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Cancer Prevention Research Institute of Texas

Completed

Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention

Lymphoma | Leukemia

United States
Institute of Cancer Research, United Kingdom
Cancer Research UK

Terminated

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Endometrial Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Active, not recruiting

Study of Weekly Radiotherapy for Bladder Cancer (HYBRID)

Bladder Cancer

United Kingdom
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Helsinn Healthcare SA

Completed

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

Nausea | Vomiting | Malignant Neoplasm

United States
M.D. Anderson Cancer Center
Cancer Prevention Research Institute of Texas

Enrolling by invitation

Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy

Delirium | Epileptics | Neuroleptics

United States
Memorial Sloan Kettering Cancer Center
Ludwig Institute for Cancer Research

Active, not recruiting

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

Colorectal Neoplasms | Colorectal Cancer | Colorectal Tumor | COlorectal Carcinoma

United States
Institute of Cancer Research, United Kingdom
Cancer Research UK

Unknown

A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT) (POUT)

Transitional Cell Carcinoma of Ureter

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Completed

Lactate Imaging as a Tumour Biomarker

Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Completed

Assessing Treatment Response in Breast Cancer With Functional Imaging

Breast Cancer

United Kingdom
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Cancer Prevention Research Institute of Texas

Active, not recruiting

Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Malignant Neoplasms of Urinary Tract | Oligometastatic Renal Cell Carcinoma

United States
Institute of Cancer Research, United Kingdom
Cancer Research UK

Completed

Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer

Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Unknown

Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery (IMPORT)

Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Unknown

A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer (PIVOTAL)

Prostate Cancer

United Kingdom
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Roswell Park Cancer Institute

Completed

Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")

Smoking Cessation

United States
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center

Completed

Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer

United States
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center

Completed

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Kidney Cancer | Renal Cell Carcinoma | Renal Cancer | Kidney Neoplasm

United States
M.D. Anderson Cancer Center
Cancer Prevention Research Institute of Texas

Recruiting

Liver Cancer Prevention Randomized Control Trial

Liver Diseases | Fibrosis, Liver | Cirrhosis, Liver

United States
M.D. Anderson Cancer Center
Cancer Prevention Research Institute of Texas

Recruiting

Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

Squamous Cell Carcinoma of the Larynx | Malignant Neoplasms of Respiratory and Intrathoracic Organs

United States
M.D. Anderson Cancer Center
Cancer Prevention Research Institute of Texas

Active, not recruiting

Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis

Liver and Intrahepatic Bile Duct Carcinoma

United States
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center

Completed

Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.

Kidney Cancer | Clear Cell Renal Cell Carcinoma | Renal Cancer | Renal Cell Carcinoma (RCC) | Renal Neoplasms | Cancer of Kidney | Neoplasms, Kidney

United States
University of Hawaii Cancer Research Center
National Cancer Institute (NCI)

Completed

Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

Breast Cancer | Healthy, no Evidence of Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
Cancer and Aging Research Group

Recruiting

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

Lymphoma | Leukemia | Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Biomarker Driven Patient Selection Neoadjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Melanoma | Advanced Melanoma | Melanoma Stage IV | Melanoma Stage III

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

Metastatic Castration-resistant Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Senior Adult Hepatobiliary Prehab Study

Cholangiocarcinoma | Liver Metastases | Hepatobiliary Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

Nonsmall Cell Lung Cancer | Nonsmall Cell Lung Cancer Stage III | Unresectable Non-Small Cell Lung Carcinoma | Nonsmall Cell Lung Cancer, Stage II

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Non Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Non Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Adenocarcinoma of Lung | Lung; Node

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

Triple Negative Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients (STRONG-GEC)

GastroEsophageal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Merkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Preop fSRS for Resectable Brain Metastases

Brain Metastases | Brain Lesion

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies

Surgical Wound Infection

United States
H. Lee Moffitt Cancer Center and Research Institute

Not yet recruiting

Intermittent Fasting for Pancreatitis (IFPanc)

Pancreatitis | Pancreatitis, Chronic | Pancreatitis, Acute | Pancreas Disease | Acute Recurrent Pancreatitis

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy

Follicular Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL) | Diffuse Large-Cell Lymphoma | Transformed Follicular Lymphoma (TFL) | High-grade B-cell Lymphoma (HGBCL)

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

Incurable Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator

Brain Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Not yet recruiting

Modifying Diet to Improve Gut Microbiome

Obesity

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

Skin Cancer | Melanoma (Skin) | Skin Carcinoma | Skin Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Florida Pancreas Collaborative Next Generation Biobank

Pancreatic Cancer | Cancer Cachexia

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Gastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

United States
Pennington Biomedical Research Center
National Cancer Institute (NCI)

Active, not recruiting

The Exercise And Colorectal Cancer Treatment Trial (EXACT)

Rectal Cancer | Colon Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC

Lung Cancer | Non Small Cell Lung Cancer | Metastatic Lung Cancer | Advanced Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | Squamous Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center

Gynecologic Cancer | Prostate Cancer | Patient Satisfaction

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy (Neoadjuvant)

Breast Cancer

United States

Clinical Trials Sponsored by Cancer Research Institute, NY, USA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations